Daiki Fukuma

1.3k total citations
26 papers, 1.0k citations indexed

About

Daiki Fukuma is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Daiki Fukuma has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Immunology. Recurrent topics in Daiki Fukuma's work include Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (10 papers) and RNA Interference and Gene Delivery (7 papers). Daiki Fukuma is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (10 papers) and RNA Interference and Gene Delivery (7 papers). Daiki Fukuma collaborates with scholars based in Japan, Germany and United States. Daiki Fukuma's co-authors include Yasuharu Nishimura, Satoru Senju, Shinya Hirata, Hidetake Matsuyoshi, Yoshihiro Yoshitake, Masanori Shinohara, Hideki Nakayama, Yutaka Motomura, Yasushi Uemura and Kenta Kawahara and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Daiki Fukuma

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daiki Fukuma Japan 18 555 508 500 127 98 26 1.0k
Dennis Knapp United States 9 284 0.5× 269 0.5× 398 0.8× 105 0.8× 49 0.5× 11 694
Shuhua Wei China 12 559 1.0× 443 0.9× 347 0.7× 157 1.2× 101 1.0× 21 1.1k
Hyung‐Gyoon Kim United States 17 197 0.4× 405 0.8× 541 1.1× 189 1.5× 86 0.9× 33 1.0k
Gulidanna Shayan United States 10 808 1.5× 771 1.5× 218 0.4× 109 0.9× 79 0.8× 20 1.2k
Malgorzata Harasymczuk United States 13 740 1.3× 462 0.9× 325 0.7× 176 1.4× 36 0.4× 16 1.1k
Yi Zeng China 14 289 0.5× 442 0.9× 285 0.6× 164 1.3× 38 0.4× 27 802
Michelle R. Padget United States 15 579 1.0× 724 1.4× 267 0.5× 75 0.6× 43 0.4× 22 1.0k
Margaret E. Gatti‐Mays United States 16 539 1.0× 746 1.5× 306 0.6× 137 1.1× 72 0.7× 74 1.1k
Akiyuki Hirosue Japan 17 179 0.3× 347 0.7× 356 0.7× 209 1.6× 138 1.4× 42 822
Y Cho Japan 9 341 0.6× 490 1.0× 218 0.4× 161 1.3× 107 1.1× 15 842

Countries citing papers authored by Daiki Fukuma

Since Specialization
Citations

This map shows the geographic impact of Daiki Fukuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiki Fukuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiki Fukuma more than expected).

Fields of papers citing papers by Daiki Fukuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiki Fukuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiki Fukuma. The network helps show where Daiki Fukuma may publish in the future.

Co-authorship network of co-authors of Daiki Fukuma

This figure shows the co-authorship network connecting the top 25 collaborators of Daiki Fukuma. A scholar is included among the top collaborators of Daiki Fukuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiki Fukuma. Daiki Fukuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishikawa, Shinji, Daiki Fukuma, Katsunobu Taki, & Takatoshi Ishiko. (2023). A case of accidental ingestion of a hooked denture without symptoms for 6 years. Journal of Surgical Case Reports. 2023(3). rjad088–rjad088.
2.
Yoshida, Ryoji, Junki Sakata, Yuichiro Matsuoka, et al.. (2020). Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy. Translational Oncology. 13(12). 100850–100850. 22 indexed citations
3.
Tsukamoto, Hirotake, Koji Fujieda, Masatoshi Hirayama, et al.. (2017). Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression. Cancer Research. 77(9). 2279–2291. 46 indexed citations
4.
Kawahara, Kenta, Akimitsu Hiraki, Ryoji Yoshida, et al.. (2017). Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report. Molecular and Clinical Oncology. 6(6). 886–892. 10 indexed citations
5.
Hiraki, Akimitsu, Takaya Yamamoto, Ryoji Yoshida, et al.. (2016). Factors affecting volume change of myocutaneous flaps in oral cancer. International Journal of Oral and Maxillofacial Surgery. 45(11). 1395–1399. 15 indexed citations
6.
Hiraki, Akimitsu, Daiki Fukuma, Masashi Nagata, et al.. (2016). Sentinel lymph node biopsy reduces the incidence of secondary neck metastasis in patients with oral squamous cell carcinoma. Molecular and Clinical Oncology. 5(1). 57–60. 15 indexed citations
8.
Hirayama, Masatoshi, Yusuke Tomita, Akira Yuno, et al.. (2016). An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. OncoImmunology. 5(6). e1123368–e1123368. 14 indexed citations
9.
Yoshitake, Yoshihiro, Daiki Fukuma, Akira Yuno, et al.. (2014). Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS. Clinical Cancer Research. 21(2). 312–321. 123 indexed citations
10.
Yoshitake, Yoshihiro, Daiki Fukuma, Akira Yuno, et al.. (2014). Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients with induced immune responses and a prolonged OS.. Journal of Clinical Oncology. 32(15_suppl). 3094–3094. 1 indexed citations
11.
Nagata, Masashi, Hideki Nakayama, Takuya Tanaka, et al.. (2011). Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma. British Journal of Cancer. 105(9). 1322–1330. 68 indexed citations
12.
Senju, Satoru, Yusuke Matsunaga, Satoshi Fukushima, et al.. (2011). Immunotherapy with pluripotent stem cell-derived dendritic cells. Seminars in Immunopathology. 33(6). 603–612. 20 indexed citations
13.
Senju, Satoru, Shinya Hirata, Yutaka Motomura, et al.. (2010). Pluripotent stem cells as source of dendritic cells for immune therapy. International Journal of Hematology. 91(3). 392–400. 23 indexed citations
14.
Fukushima, Satoshi, Shinya Hirata, Yutaka Motomura, et al.. (2009). Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide–loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells. Journal of Immunotherapy. 32(3). 219–231. 22 indexed citations
15.
Shinriki, Satoru, Mitsuharu Ueda, Kazutoshi Ota, et al.. (2009). Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma. Journal of Oral Pathology and Medicine. 39(1). 41–47. 8 indexed citations
16.
Hirata, Shinya, Hidetake Matsuyoshi, Daiki Fukuma, et al.. (2007). Involvement of Regulatory T Cells in the Experimental Autoimmune Encephalomyelitis-Preventive Effect of Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein plus TRAIL. The Journal of Immunology. 178(2). 918–925. 42 indexed citations
17.
Senju, Satoru, Hirofumi Suemori, Hitoshi Zembutsu, et al.. (2007). Genetically Manipulated Human Embryonic Stem Cell-Derived Dendritic Cells with Immune Regulatory Function. Stem Cells. 25(11). 2720–2729. 45 indexed citations
19.
Fukuma, Daiki, Hidetake Matsuyoshi, Shinya Hirata, et al.. (2005). Cancer prevention with semi-allogeneic ES cell-derived dendritic cells. Biochemical and Biophysical Research Communications. 335(1). 5–13. 27 indexed citations
20.
Matsuyoshi, Hidetake, Shinya Hirata, Yoshihiro Yoshitake, et al.. (2005). Therapeutic effect of α‐galactosylceramide‐loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells. Cancer Science. 96(12). 889–896. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026